{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T11:08:26Z","timestamp":1782299306915,"version":"3.54.5"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["Z1A DA000424"],"award-info":[{"award-number":["Z1A DA000424"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.neuropharm.2018.08.016","type":"journal-article","created":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T12:20:50Z","timestamp":1534767650000},"page":"11-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Genetic deletion of the dopamine D3 receptor increases vulnerability to heroin in mice"],"prefix":"10.1016","volume":"141","author":[{"given":"Jia","family":"Zhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe J.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-hua","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-hu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliot L.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Xiong","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2018.08.016_bib1","article-title":"Abnormalities of dopamine D3 receptor signaling in the diseased brain","volume":"9","author":"Aleph Prieto","year":"2017","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"10.1016\/j.neuropharm.2018.08.016_bib3","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/pr.110.002642","article-title":"The physiology, signaling, and pharmacology of dopamine receptors","volume":"63","author":"Beaulieu","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2018.08.016_bib4","doi-asserted-by":"crossref","first-page":"6195","DOI":"10.1021\/acs.jmedchem.5b00776","article-title":"High affinity dopamine D3 receptor (D3R)-Selective antagonists attenuate heroin self-administration in wild-type but not D3R knockout mice","volume":"58","author":"Bouteng","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2018.08.016_bib5","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1038\/npp.2016.108","article-title":"Heightened dopaminergic response to amphetamine at the D3 dopamine receptor in methamphetamine users","volume":"41","author":"Boileau","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.08.016_bib6","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1038\/sj.npp.1300536","article-title":"Individual differences in cocaine- and amphetamine-induced activation of male Sprague-Dawley rats: contribution of the dopamine transporter","volume":"29","author":"Briegleb","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.08.016_bib7","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1037\/a0029135","article-title":"Cocaine self-administration in dopamine D(3) receptor knockout mice","volume":"20","author":"Caine","year":"2012","journal-title":"Exp. Clin. Psychopharmacol"},{"key":"10.1016\/j.neuropharm.2018.08.016_bib8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.nbd.2014.12.007","article-title":"Prolonged treatment with pramipexole promotes physical interaction of striatal dopamine D3 autoreceptors with dopamine transporters to reduce dopamine uptake","volume":"74","author":"Castro-Hernandez","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2018.08.016_bib9","series-title":"2015 National Survey on Drug Use and Health","author":"Center for Behavioral Health Statistics and Quality","year":"2016"},{"key":"10.1016\/j.neuropharm.2018.08.016_bib11","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3389\/fphar.2014.00116","article-title":"It's MORe exciting than mu: crosstalk between mu opioid receptors and glutamatergic transmission in the mesolimbic dopamine system","volume":"5","author":"Chartoff","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.08.016_bib13","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/j.1471-4159.2009.06209.x","article-title":"The D(3) dopamine receptor inhibits dopamine release in PC-12\/hD3 cells by autoreceptor signaling via PP-2B, CK1, and Cdk-5","volume":"110","author":"Chen","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2018.08.016_bib14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0165-6147(99)01422-4","article-title":"Dopamine receptor partial agonists could address the duality of cocaine craving","volume":"21","author":"Childress","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2018.08.016_bib15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.addbeh.2017.05.030","article-title":"Increased use of heroin as an initiating opioid of abuse","volume":"74","author":"Cicero","year":"2017","journal-title":"Addict. Behav."},{"key":"10.1016\/j.neuropharm.2018.08.016_bib16","doi-asserted-by":"crossref","first-page":"5846","DOI":"10.1523\/JNEUROSCI.0310-17.2017","article-title":"D3 receptors regulate excitability in a unique class of prefrontal pyramidal cells","volume":"37","author":"Clarkson","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.08.016_bib17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1211\/0022357991772123","article-title":"Characterization of dopamine receptor subtypes involved in experimentally induced gastric and duodenal ulcers in rats","volume":"51","author":"Desai","year":"1999","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.08.016_bib18","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1046\/j.1460-9568.1998.00368.x","article-title":"Drug-induced reinstatement of heroin- and cocaine-seeking behaviour following long-term extinction is associated with expression of behavioural sensitization","volume":"10","author":"De Vries","year":"1998","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.08.016_bib19","doi-asserted-by":"crossref","first-page":"8677","DOI":"10.1523\/JNEUROSCI.20-23-08677.2000","article-title":"Dopamine D3 receptors expressed by all mesencephalic dopamine neurons","volume":"20","author":"Diaz","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.08.016_bib20","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/sj.mp.4000409","article-title":"Homozygosity at the dopamine D3 receptor gene is associated with opiate dependence","volume":"3","author":"Duaux","year":"1998","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.08.016_bib21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.tins.2015.01.002","article-title":"Understanding opioid reward","volume":"38","author":"Fields","year":"2015","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2018.08.016_bib22","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1097\/00001756-200410050-00021","article-title":"Role of DRD3 in morphine-induced conditioned place preference using drd3-knockout mice","volume":"15","author":"Frances","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2018.08.016_bib23","series-title":"Psychostimulant Actions on Dopamine and Limbic System Function: Relevance to the Pathophysiology and Treatment of ADHD. Pp. 134\u2013157","author":"Grace A","year":"2001"},{"key":"10.1016\/j.neuropharm.2018.08.016_bib24","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2174\/187152708786927822","article-title":"Selective antagonism at dopamine D3 receptors as a target for drug addiction pharmacotherapy: a review of preclinical evidence","volume":"7","author":"Heidbreder","year":"2008","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"key":"10.1016\/j.neuropharm.2018.08.016_bib25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1749-6632.2009.05149.x","article-title":"Current perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders","volume":"1187","author":"Heidbreder","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2018.08.016_bib26","article-title":"The societal cost of heroin use disorder in the United States","volume":"12","author":"Jiang","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2018.08.016_bib27","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1146\/annurev-publhealth-031914-122957","article-title":"The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction","volume":"36","author":"Kolodny","year":"2015","journal-title":"Annu. Rev. Publ. Health"},{"key":"10.1016\/j.neuropharm.2018.08.016_bib28","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.neuroscience.2010.12.008","article-title":"Activation of dopamine D3 receptors inhibits reward-related learning induced by cocaine","volume":"176","author":"Kong","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2018.08.016_bib29","series-title":"US heroin Deaths Jump 533% since 2002, Report Says","author":"Kounang","year":"2017"},{"key":"10.1016\/j.neuropharm.2018.08.016_bib30","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1037\/1064-1297.9.3.297","article-title":"Drug-induced reinstatement to heroin and cocaine seeking: a rodent model of relapse in polydrug use","volume":"9","author":"Leri","year":"2001","journal-title":"Exp. Clin. Psycopharmacol."},{"key":"10.1016\/j.neuropharm.2018.08.016_bib31","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00429-012-0383-8","article-title":"Molecular characterization of individual D3 dopamine receptor-expressing cells isolated from multiple brain regions of a novel mouse model","volume":"217","author":"Li","year":"2012","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.neuropharm.2018.08.016_bib32","series-title":"Trends in Heroin Use in the United States: 2002 to 2013","author":"Lipari","year":"2013"},{"key":"10.1016\/j.neuropharm.2018.08.016_bib33","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.drugalcdep.2014.03.013","article-title":"Dopamine D(3) receptor alterations in cocaine-dependent humans imaged with [(1)(1)C](+)PHNO","volume":"139","author":"Matuskey","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2018.08.016_bib34","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/jnc.13732","article-title":"Dopamine D3 autoreceptor inhibition enhances cocaine potency at the dopamine transporter","volume":"138","author":"McGinnis","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2018.08.016_bib35","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1523\/JNEUROSCI.23-03-01006.2003","article-title":"Molecular evidence for the functional role of dopamine D3 receptor in the morphine-induced rewarding effect and hyperlocomotion","volume":"23","author":"Narita","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.08.016_bib36","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1523\/JNEUROSCI.20-11-04226.2000","article-title":"Vertical shifts in self-administration dose-response functions predict a drug-vulnerable phenotype predisposed to addiction","volume":"20","author":"Piazza","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.08.016_bib37","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neubiorev.2005.04.016","article-title":"The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse?","volume":"30","author":"Pierce","year":"2006","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2018.08.016_bib38","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s11920-014-0504-6","article-title":"Genetics of opiate addiction","volume":"16","author":"Reed","year":"2014","journal-title":"Curr. Psychiatr. Rep."},{"key":"10.1016\/j.neuropharm.2018.08.016_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-0270(95)00153-0","article-title":"Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy","volume":"66","author":"Richardson","year":"1996","journal-title":"J. Neurosci. Meth."},{"key":"10.1016\/j.neuropharm.2018.08.016_bib40","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.pnpbp.2017.06.009","article-title":"Opiate exposure state controls dopamine D3 receptor and cdk5\/calcineurin signaling in the basolateral amygdala during reward and withdrawal aversion memory formation","volume":"79","author":"Rosen","year":"2017","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.08.016_bib41","doi-asserted-by":"crossref","first-page":"8406","DOI":"10.1523\/JNEUROSCI.1958-08.2008","article-title":"Dissociation between rewarding and psychomotor effects of opiates: differential roles for glutamate receptors within anterior and posterior portions of the ventral tegmental area","volume":"28","author":"Shabat-Simon","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.08.016_bib42","first-page":"176","article-title":"Lapse and relapse following inpatient treatment of opiate dependence","volume":"103","author":"Smyth","year":"2010","journal-title":"Ir. Med. J."},{"key":"10.1016\/j.neuropharm.2018.08.016_bib43","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/ejn.13390","article-title":"The dopamine D3 receptor, a quarter century later","volume":"45","author":"Sokoloff","year":"2017","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.08.016_bib44","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.bcp.2013.04.013","article-title":"Adolescence methylphenidate treatment in a rodent model of attention deficit\/hyperactivity disorder: dopamine transporter function and cellular distribution in adulthood","volume":"86","author":"Somkuwar","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.08.016_bib45","doi-asserted-by":"crossref","first-page":"17675","DOI":"10.1073\/pnas.1205297109","article-title":"Increased vulnerability to cocaine in mice lacking dopamine D3 receptors","volume":"109","author":"Song","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2018.08.016_bib46","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.pbb.2008.02.003","article-title":"The effects of two highly selective dopamine D3 receptor antagonists (SB-277011A and NGB-2904) on food self-administration in a rodent model of obesity","volume":"89","author":"Thanos","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2018.08.016_bib47","author":"U.S. Department of Health and Human Services"},{"key":"10.1016\/j.neuropharm.2018.08.016_bib48","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1177\/0269881114531664","article-title":"Dopamine D2\/3 receptor availability and amphetamine-induced dopamine release in obesity","volume":"28","author":"van de Giessen","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2018.08.016_bib49","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.cell.2015.07.046","article-title":"The brain on drugs: from reward to addiction","volume":"162","author":"Volkow","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2018.08.016_bib50","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1467-789X.2012.01031.x","article-title":"Obesity and addiction: neurobiological overlaps","volume":"14","author":"Volkow","year":"2013","journal-title":"Obes. Rev."},{"key":"10.1016\/j.neuropharm.2018.08.016_bib51","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4238\/2015.January.16.1","article-title":"Dopamine receptor D1 but not D3 essential for morphine-induced conditioned responses","volume":"14","author":"Wang","year":"2015","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.neuropharm.2018.08.016_bib52","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1527-3458.2007.00013.x","article-title":"Pharmacological actions of NGB 2904, a selective dopamine D3 receptor antagonist, in animal models of drug addiction","volume":"13","author":"Xi","year":"2007","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.neuropharm.2018.08.016_bib53","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0896-6273(00)80965-4","article-title":"Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors","volume":"19","author":"Xu","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2018.08.016_bib54","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1126\/science.1114313","article-title":"Increased lever pressing for amphetamine after pimozide in rats: implications for a dopamine theory of reward","volume":"187","author":"Yokel","year":"1975","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2018.08.016_bib55","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neuropharm.2017.09.007","article-title":"The novel dopamine D3 receptor antagonists\/partial agonists CAB2-015 and BAK4-54 inhibit oxycodone-taking and oxycodone-seeking behavior in rats","volume":"126","author":"You","year":"2017","journal-title":"Neuropharmacology"},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2018.08.016_bib56","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.neuropharm.2004.07.010","article-title":"Rapid regulation of the dopamine transporter: role in stimulant addiction?","volume":"47","author":"Zahniser","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.08.016_bib57","doi-asserted-by":"crossref","first-page":"35842","DOI":"10.1074\/jbc.M611758200","article-title":"Regulation of dopamine transporter function and cell surface expression by D3 dopamine receptors","volume":"282","author":"Zapata","year":"2007","journal-title":"J. Biol. Chem."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818305318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818305318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T12:19:17Z","timestamp":1538223557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390818305318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":54,"alternative-id":["S0028390818305318"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.08.016","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic deletion of the dopamine D3 receptor increases vulnerability to heroin in mice","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}